Startups.Bio showcases an emerging biotech startup each week, selected by the analyst team at VentureRadar from the 10,000s of companies we track.
In the past three months we’ve featured 11 biotech startups, working on a range new approaches to tackling major diseases. You can find out more about the startups in the summaries below, or head across to the VentureRadar Database to find thousands more biotech companies like these ones. Ancilia Biosciences Ancilia Biosciences develops novel bacterial […]
View post to subscribe to site newsletter.
Ancilia Biosciences develops novel bacterial therapies that target the viral components of the microbiome to address chronic diseases across immunology and oncology indications. The company is developing a proprietary platform that leverages the natural function of CRISPR to produce a new class of live biotherapeutics (LBPs) with engineered immunity to viral phages. These viral phages, […]
View post to subscribe to site newsletter.
Kanvas Bioscience wants to revolutionize microbial research and infectious disease diagnostics with next generation imaging technology that is able to provide deeper information on the spacial organisation and behaviour of microbial communities. The company’s highly multiplexed imaging technology originates from Cornell University and uses a two-step process called high phylogenetic resolution microbiome mapping by fluorescence […]
View post to subscribe to site newsletter.